US Patent 8030336 Nicotinamide-based kinase inhibitors
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+300 characters)
Article
Patent abstract
A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08030336 Nicotinamide-based kinase inhibitors US Patent 8030336 Nicotinamide-based kinase inhibitors
Infobox
Patent Number
0803033600
Patent Number
803033600
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
080303360
Date of Patent
October 4, 2011
0Patent Application Number
105377190
Date Filed
December 15, 2003
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
080303360
Date of Patent
October 4, 2011
0Patent Application Number
105377190
Date Filed
December 15, 2003
0Patent Primary Examiner
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08030336 Nicotinamide-based kinase inhibitors
Infobox
Is a
Patent jurisdiction
Patent number
08030336
Date of patent
October 4, 2011
Patent application number
10537719
Date Filed
December 15, 2003
Patent primary examiner
Find more entities like US Patent 8030336 Nicotinamide-based kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.